Robert J - Search Results

1

Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a model.

Charasson V, Hillaire-Buys D, Solassol I, Laurand-Quancard A, Pinguet F, Le Morvan V, Robert J. Charasson V, et al. Among authors: robert j. Eur J Cancer. 2009 Sep;45(13):2391-401. doi: 10.1016/j.ejca.2009.05.013. Epub 2009 Jun 6. Eur J Cancer. 2009. PMID: 19501504

2

Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel.

Nief N, Le Morvan V, Robert J. Nief N, et al. Among authors: robert j. Eur J Cancer. 2007 Mar;43(5):955-62. doi: 10.1016/j.ejca.2006.12.012. Epub 2007 Feb 20. Eur J Cancer. 2007. PMID: 17317154

3

Impact of EGFR gene polymorphisms on anticancer drug cytotoxicity in vitro.

Puyo S, Le Morvan V, Robert J. Puyo S, et al. Among authors: robert j. Mol Diagn Ther. 2008;12(4):225-34. doi: 10.1007/BF03256288. Mol Diagn Ther. 2008. PMID: 18652519

4

Identification of gene polymorphisms of human DNA topoisomerase I in the National Cancer Institute panel of human tumour cell lines.

Moisan F, Longy M, Robert J, Le Morvan V. Moisan F, et al. Among authors: robert j. Br J Cancer. 2006 Oct 9;95(7):906-13. doi: 10.1038/sj.bjc.6603361. Epub 2006 Sep 19. Br J Cancer. 2006. PMID: 16983402 Free PMC article.

5

Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel.

Le Morvan V, Bellott R, Moisan F, Mathoulin-Pélissier S, Bonnet J, Robert J. Le Morvan V, et al. Among authors: robert j. Pharmacogenomics. 2006 Sep;7(6):843-52. doi: 10.2217/14622416.7.6.843. Pharmacogenomics. 2006. PMID: 16981845

6

Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.

Meynard D, Le Morvan V, Bonnet J, Robert J. Meynard D, et al. Among authors: robert j. Oncol Rep. 2007 May;17(5):1213-21. Oncol Rep. 2007. PMID: 17390068

7

Functional study of the 830C>G polymorphism of the human carboxylesterase 2 gene.

Bellott R, Le Morvan V, Charasson V, Laurand A, Colotte M, Zanger UM, Klein K, Smith D, Bonnet J, Robert J. Bellott R, et al. Among authors: robert j. Cancer Chemother Pharmacol. 2008 Mar;61(3):481-8. doi: 10.1007/s00280-007-0493-9. Epub 2007 May 5. Cancer Chemother Pharmacol. 2008. PMID: 17483951

8

[Biological bases for individualising prescriptions in oncology: the germline genome].

Robert J, Le Morvan V. Robert J, et al. Bull Cancer. 2008 Oct;95(10):911-21. doi: 10.1684/bdc.2008.0722. Bull Cancer. 2008. PMID: 19004720 French.

9

Cytochrome P450 1B1 gene polymorphisms as predictors of anticancer drug activity: studies with in vitro models.

Laroche-Clary A, Le Morvan V, Yamori T, Robert J. Laroche-Clary A, et al. Among authors: robert j. Mol Cancer Ther. 2010 Dec;9(12):3315-21. doi: 10.1158/1535-7163.MCT-10-0673. Epub 2010 Oct 1. Mol Cancer Ther. 2010. PMID: 20889730

10

On the use of pharmacogenetics in cancer treatment and clinical trials.

Robert J, Le Morvan V, Giovannetti E, Peters GJ; PAMM Group of EORTC. Robert J, et al. Eur J Cancer. 2014 Oct;50(15):2532-43. doi: 10.1016/j.ejca.2014.07.013. Epub 2014 Aug 4. Eur J Cancer. 2014. PMID: 25103456 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,193 results

Search Page

Filters